Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders

Explore clinical trials studying Blood Coagulation Disorders. Study availability and eligibility vary by location and protocol.

1,481 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders trial results

Completed

Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study)

NCT04091386

Conditions
Behavior, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +8 more
Locations
  • Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders Orange, California, United States
  • Tulane University New Orleans, Louisiana, United States
  • Many Locations Multiple Locations, Belgium
  • Many Locations Multiple Locations, Canada
View Trial Details
Completed

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

NCT04278924

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Arizona Clinical Research Center - Hunt - PPDS Tucson, Arizona, United States
  • University of Florida Gainesville, Florida, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 55 locations
View Trial Details
Completed

Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects

NCT00868530

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Pfizer Investigational Site Suzhou, Jiangsu, China
  • Pfizer Investigational Site Heping District, Tianjin Municipality, China
  • Pfizer Investigational Site Hangzhou, Zhejiang, China
  • Pfizer Investigational Site Beijing, China
View Trial Details
Completed

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

NCT03938792

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • USF Health Morsani Center For Advanced Healthcare Tampa, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • Northwell Health HTC New Hyde Park, New York, United States
  • Washington Institute for Coagulation Seattle, Washington, United States
View all 62 locations
View Trial Details
Completed

A Proof-of-concept Study to Reduce Treatment Burden in Haemophilia Participants Receiving Factor VIII and Factor IX Infusions

NCT05437211

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Centre de Reference Hemophilie Unite D'Hemostase Clinique Bron, Auvergne-Rhône-Alpes, France
  • CHU Estaing Clermont-Ferrand, Auvergne-Rhône-Alpes, France
  • Hôpital de Hautepierre - Pôle MIRMED Strasbourg, Grand Est, France
  • CHU Purpan Toulouse, Haute-Garonne, France
View Trial Details
Completed

Sepsis-Associated Purpura Fulminans International Registry - Europe

NCT02238795

Conditions
Blood Coagulation Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • University Hospital Jena, Klinik für Anästhesiologie und Intensivmedizin Jena, Germany
  • University Hospital Jena, Klinik für Kinder- und Jugendmedizin Jena, Germany
  • Klinikum der Universität München Munich, Germany
View Trial Details
Completed

A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

NCT04346654

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Novartis Investigative Site Aschaffenburg, Bavaria, Germany
  • Novartis Investigative Site Aachen, Germany
  • Novartis Investigative Site Chemnitz, Germany
  • Novartis Investigative Site Donauwörth, Germany
View Trial Details
Completed

A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A

NCT05707351

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Beijing Children's Hospital, Capital Medical University Beijing, China
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, China
  • Xiangya Hospital of Central South University Changsha, China
  • Fujian Medical University Union Hospital Fuzhou, China
View Trial Details

Related conditions